Published guidance, NICE advice and quality standards

Showing 31 to 40 of 2050

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Adalimumab, etanercept and ustekinumab for treating plaque psoriasis in children and young people	TA455	12 July 2017	12 July 2017
Adalimumab, etanercept, infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed	TA715	14 July 2021	14 July 2021
Adalimumab, etanercept, infliximab, certolizumab pegol, golimumab, tocilizumab and abatacept for rheumatoid arthritis not previously treated with DMARDs or after conventional DMARDs only have failed	TA375	26 January 2016	26 January 2016
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitor	TA195	25 August 2010	25 August 2010
Adefovir dipivoxil and peginterferon alfa-2a for the treatment of chronic hepatitis B	TA96	22 February 2006	22 February 2006
Adjunctive colposcopy technologies for assessing suspected cervical abnormalities: the DYSIS colposcope with DYSISmap and the ZedScan I	DG32	25 April 2018	25 April 2018
Advanced breast cancer: diagnosis and treatment	CG81	23 February 2009	16 August 2017
Advocacy services for adults with health and social care needs	NG227	9 November 2022	9 November 2022
Afamelanotide for treating erythropoietic protoporphyria	HST27	26 July 2023	26 July 2023
Afatinib for treating advanced squamous non-small-cell lung cancer after platinum-based chemotherapy (terminated appraisal)	TA444	24 May 2017	24 May 2017